Evert B. Schimmelpennink
President, CEO, Secretary & DirectorMr. Evert B. Schimmelpennink, also known as Eef, serves as Director of Pipeline Therapeutics, Inc. since February 2022. He serves as an Independent Director at Contineum Therapeutics, Inc. since January 2022 and serves as its Chairman of the Board since March 2024. He is a seasoned biotechnology executive with experience in research and development, commercial growth, manufacturing and business development. He has served as President, Chief Executive Officer and Directors at LENZ Therapeutics, Inc. since March 2024. Mr. Schimmelpennink served as LENZ OpCo’s President and Chief Executive Officer and a member of its board of directors from March 2021 through the closing of the Merger and serves as Secretary and also served as its Chief Financial Officer. He served as President and Chief Executive Officer at Pfenex Inc since August 2017 until October 2020. He served as Director at Business Development at Synthon BV since January 2007 until December 2007 and Business Development Manager since April 2006 until December 2007. He served as Senior International Product Manager since January 2005 until March 2006 and International Product Manager since October 2002 until December 2004. He served as International Product Manager at Numico since December 2000 until September 2002 and Researcher Product Development since September 1997 until November 2000. He served as an Independent Director of iBio, Inc. since April 2019 until 2026. He had been Chief Executive Officer, President and Secretary of Pfenex Inc. since August 3, 2017. Mr. Schimmelpennink served as Chief Financial Officer & Principal Financial and Accounting Officer of Pfenex Inc. since November 13, 2019. Mr. Schimmelpennink served as Chief Executive Officer at ALVOTECH ehf. from October 2015 to July 3, 2017. He has global generic pharmaceutical experience and has a strong record of accomplishment of delivering profitable growth. Prior to joining Alvotech, he served as Vice President of Global at Sterile Injectibles Pfizer from September 2015 to November 2015. He served as Vice President of Global Generics at Hospira from December 2012 to August 2015 and Director of Specialty Injectable Pharma Marketing EMEA & Director of Distributor Operations EMEA from March 2011 to December 2012 of Hospira, Inc. From 2002 to 2011, he has also held various senior commercial leadership positions at Synthon BV, including Vice President Marketing and Sales from 2008 to 2011. From 1997 to 2002, he held various roles with Numico NV, including International Product Manager from 2000 to 2002 and Researcher Product Development from 1999 to 2000. Prior to Numico, Mr. Schimmelpennink served as a vaccine technologist at the Dutch National Institute for Public Health and the Environment from 1998 to 1999. He had been a Director of Pfenex Inc. since August 3, 2017. Mr. Schimmelpennink received a MSc in Bioprocess Engineering from the Wageningen University & Research from 1991 to 1997 and Bioprocess Engineering in Queensland University of Technology from 1995 to 1996 and studied business from Business School Arnhem from 2001 to 2004.
Positions
- Company NameLENZ Therapeutics, Inc.Stock CodeLENZPositionPresident, CEO, Secretary & DirectorColleagues
- EBEvert B. SchimmelpenninkPresident, CEO, Secretary & Director
- JPJeffrey P. GeorgeIndependent Chairman
- JWJames W. McCollumCo-Founder & Director
- SOShawn OlssonChief Commercial Officer
- MGMarc G. OdrichChief Medical Officer
- DRDaniel R. ChevallardCFO, Principal Financial & Accounting Officer
- FGFrederic GuerardIndependent Director
- SBShelley B. ThunenIndependent Director
- Company NameContineum Therapeutics, Inc.Stock CodeCTNMPositionIndependent Chairman of the BoardColleagues
- CNCarmine N. StengonePresident, CEO & Director
- PTPeter T. SloverChief Financial Officer
- TRTimothy R. WatkinsChief Medical Officer & Head of Development
- MPMorgan PaulsenSenior Manager of Accounting
- DSDaniel S. LorrainChief Science Officer
- TRTodd R. BradyIndependent Director
- TATroy A. IgnelziIndependent Director
- SBSarah BoyceIndependent Director
